Learn About DecisionDx–SCC
Learn About DecisionDx–SCC
Learn About DecisionDx–SCC
Cutaneous squamous cell carcinoma (SCC) is the second-most common type of skin cancer, leading to significant surplus mortality. In this webinar, Jason Newman, MD, FACS, Professor of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania and director of the Cancer Service Line at Pennsylvania Hospital, explains how DecisionDx-SCC helps improve patient outcomes.
“This 40-GEP test can complement our clinical way of assessing risk for patients, allowing us to make better decisions in the management of their care.”
– Professor Jason Newman, MD, FACS
By the numbers
How SCC impacts patients
1.8M
SCC cases are diagnosed
in the U.S. every year
2-6%
of SCC cases metastasize,
leading to increased mortality
>14,000
annual deaths in the U.S.
are attributed to SCC
By the numbers
How SCC impacts patients